You Position: Home > Paper
多重耐药时代经验性治疗的抗菌药物定位
( views:332, downloads:668 )
- Author:
- No author available
- Journal Title:
- Chinese Journal of Tuberculosis and Respiratory Diseases
- Issue:
- 5
- DOI:
- 10.3760/cma.j.issn.1001-0939.2012.05.025
- Key Word:
- No keyword available
Abstract： 细菌耐药已成为全球不容忽视的问题.抗生素选择性压力是导致和加速耐药性产生的主要因素,包括不适当的选用抗菌药物、药物剂量或疗程不足及抗菌药物质量低劣等[1].为加强医疗机构抗菌药物临床应用管理,有效控制细菌耐药,2011年我国制定了“全国抗菌药物临床应用专项整治活动方案”和“抗菌药物临床应用管理办法(征求意见稿)”[2-3].2012年,为进一步巩固2011年专项整治成果,制订了“2012年全国抗菌药物临床应用专项整治活动方案”[4].新方案不仅提出要加大抗菌药物临床应用相关指标的控制力度,同时还要对2011年度院、科两级抗菌药物使用率及使用强度的应用情况开展调查.总之,限制和减缓细菌的耐药性已成为当务之急,而降低抗菌药物的使用率和使用强度已成为我国抗生素管理的核心内容.
- [1]张智洁,吴丽娜,王艳玲,等.Mohnarin2009年度报告：65岁以上老年患者细菌耐药监测[J].2011,(7).
- [2]汪复,朱德妹,胡付品,等.2008年中国CHINET细菌耐药性监测[J].2009,(5).
- [3]王韧韬,佘丹阳.碳青霉烯类抗生素联合舒巴坦治疗耐药鲍曼不动杆菌导致的医院获得性肺炎[J].2011,(7).
- [4]朱德妹,张婴元,汪复,等.2009年上海地区细菌耐药性监测[J].2010,(6).
- [5]司文秀,杨继章,杨树民.抗菌药物诱导内毒素的产生及抗内毒素药物的研究进展[J].2007,(8).
- [6]朱德妹,汪复,胡付品,等.2010年中国CHINET细菌耐药性监测[J].2011,(5).
- [7]汪复,朱德妹,胡付品,等.2009年中国CHINET细菌耐药性监测[J].2010,(5).
- [8]吕媛,李耘,郑波.国内外细菌耐药监测研究介绍[J].2011,(4).
- [9]刘根焰,童明庆,梅亚宁,等.Mohnarin2009年度报告：青壮年（14-65岁）来源菌株耐药监测[J].2011,(7).
- [10]Apisarnthanarak, A.,Kiratisin, P.,Kaewdaeng, S..Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates[J].2010,36(3).
- [11]J J, Jackson,H, Kropp.beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime.[J].1992,165.
- [12]Marianna, Ofner-Agostini,Andrew, Simor,Michael, Mulvey,etc.Risk factors for and outcomes associated with clinical isolates of Escherichia coli and Klebsiella species resistant to extended-spectrum cephalosporins among patients admitted to Canadian hospitals.[J].2009,20(3).
- [13]Fujimura S,Nukiwa T,Gomi K,etc.Evaluation of dosing designs of carbapenems for severe respiratory infection using Monte Carlo simulation.[J].2007,13(5).
- [14]T, Hashizume,F, Ishino,J, Nakagawa,etc.Studies on the mechanism of action of imipenem (N-formimidoylthienamycin) in vitro: binding to the penicillin-binding proteins (PBPs) in Escherichia coli and Pseudomonas aeruginosa, and inhibition of enzyme activities due to the PBPs in E. coli.[J].1984,37.
- [15]Liu D,Xu Y,Liu H,etc.Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.[J].2002,28(12).
- [16]R H, Eng,S M, Smith,P, Fan-Havard,etc.Effect of antibiotics on endotoxin release from gram-negative bacteria.[J].1900,16.
- [17]Doo Ryeon Chung,Kwan Soo Ko,Kyong Ran Peck,etc.Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.[J].2012,91(1).
- [18]Sudsai T,Jaruratanasirikul S.Comparison of the pharmacodynamics of imipenem in patients with ventilator-associated pneumonia following administration by 2 or 0.5 h infusion.[J].2009,63(3).
- [19]Siriluck, Anunnatsiri,Pantipa, Tonsawan.Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.[J].2011,42.
- [20]王进,王喆,刘健,等.碳青霉烯类药物对铜绿假单胞菌体外抗菌行为比较[J].2009,(12).
- [21]Azim A,Baronia AK,Dhole TN,etc.Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum beta-lactamase- and metallo-beta-lactamase-producing Gram-negative bacteria--an Indian experience.[J].2010,59(8).
- [22]汪复, 张婴元, 主编.实用抗感染治疗学[M].2011.
- [23]Rodloff AC,Torres A,Goldstein EJ.Two decades of imipenem therapy.[J].2006,58(5).
- [24]周向东,阳涛.抗生素杀菌过程致内毒素释放的比较性研究[J].1998,(10).
- [25]Mazuski JE,Bradley J,Solomkin JS.Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.[J].2010,50(2).
- [26]Trecarichi EM,Cauda R,Tumbarello M,etc.Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.[J].2007,51(6).
- [27]Johann D.D. Pitout.Infections with Extended-Spectrum beta-Lactamase-Producing Enterobacteriaceae Changing Epidemiology and Drug Treatment Choices[J].2010,70(3).
- [28]NARITA Kayou,KOIDE Naoki,MORIKAWA Akiko,etc.DIFFERENTIAL RELEASE OF ENDOTOXIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH ^|^beta; -LACTAM ANTIBIOTICS AND ITS EFFECT ON THE LETHAL ACTIVITY[J].1997.
- [29]Seifert H,Peleg AY,Paterson DL.Acinetobacter baumannii: emergence of a successful pathogen.[J].2008,21(3).
- [30]陈丽丹,游升荣,张有江,等.急诊科重症监护病房鲍氏不动杆菌分布调查[J].2010,(8).